Cardioplegia in paediatric cardiac surgery: a systematic review of randomized controlled trials

Nigel E Drury1,2, Ivan Yim1, Akshay J Patel1

  • 1Department of Paediatric Cardiac Surgery, Birmingham Children's Hospital, Birmingham, UK.

Insights

This systematic review found limited evidence on cardioplegia for myocardial protection in pediatric cardiac surgery due to small, low-quality trials. Developing a core outcome set is crucial for future high-quality research in pediatric cardioplegia.

Area of Science:

  • Pediatric Cardiac Surgery
  • Cardiovascular Research
  • Evidence-Based Medicine

Background:

  • Cardioplegia is essential for protecting the heart muscle during cardiac surgery.
  • Evaluating the existing evidence on cardioplegia in pediatric patients is critical for improving surgical outcomes.
  • A systematic review was conducted to assess the quality and scope of randomized controlled trials (RCTs) concerning cardioplegia in children.

Purpose of the Study:

  • To systematically review and evaluate the current evidence base of randomized controlled trials (RCTs) on cardioplegia for myocardial protection in pediatric cardiac surgery.
  • To identify the types of cardioplegia solutions and additives studied in children.
  • To assess the quality and limitations of existing research.

Main Methods:

  • A comprehensive search of MEDLINE, CENTRAL, and LILACS databases was performed.
  • Included were RCTs comparing cardioplegia solutions or additives in pediatric cardiac surgery patients; excluded were secondary publications and studies with inseparable adult data.
  • Data extraction and risk of bias assessment using the Cochrane Risk of Bias tool were conducted independently by at least two reviewers.

Main Results:

  • Twenty-six trials involving 1596 children were identified, all single-center Phase II trials with small patient numbers.
  • The most common comparisons involved blood versus crystalloid cardioplegia.
  • Frequent outcome measures included biomarkers of myocardial injury, inotrope requirements, and intensive care unit length of stay, but heterogeneity precluded meta-analysis.

Conclusions:

  • The current literature on pediatric cardioplegia lacks late-phase trials and is characterized by small sample sizes, inconsistent endpoints, and low methodological quality.
  • The limited evidence base necessitates the development of a core outcome set for standardized, validated endpoints.
  • High-quality, multicenter trials are needed to establish best practices for myocardial protection in pediatric cardiac surgery.
Abstract

Related Concept Videos

Random and Systematic Errors01:20

Random and Systematic Errors

Scientists always try their best to record measurements with the utmost accuracy and precision. However, sometimes errors do occur. These errors can be random or systematic. Random errors are observed due to the inconsistency or fluctuation in the measurement process, or variations in the quantity itself that is being measured. Such errors fluctuate from being greater than or less than the true value in repeated measurements. Consider a scientist measuring the length of an earthworm using a...
15.2K
Review and Preview01:10

Review and Preview

In statistics, several tools are used to interpret the data. Measures of central tendency represent the characteristics of the data, such as mean, median, and mode. Additionally, measures of variance like standard deviation and range are used to find the spread of data from the mean. Relative standing measures the distance between data locations. Commonly used measures of relative standings are percentile, z score, and quartiles.
Percentiles are a type of fractile that partition data into...
8.4K
Review and Preview01:13

Review and Preview

Data are individual items of information obtained from a population or sample. Data may be classified as qualitative (categorical), quantitative continuous, or quantitative discrete. Because it is not practical to measure the entire population in a study, researchers use samples to represent the population. A random sample is a representative group from the population chosen by using a method that gives each individual in the population an equal chance of being included in the sample. Random...
11.5K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.0K
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
425
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.8K